SCHEMBL8879002

SCHEMBL8879002

O=C(O)C(CCCCOCc1ccccc1)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 4/20 0.49
MMP8 P22894 4/20 0.49
MMP9 P14780 3/20 0.49
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TSHR P16473 1/20 0.47
FOLH1 Q04609 1/20 0.47
MMP1 P03956 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
EPHX2 P34913 1/20 0.46
SLC1A1 P43005 3/20 0.45
TDP1 Q9NUW8 1/20 0.45
TEAD3 Q99594 1/20 0.45
GBA1 P04062 2/20 0.43
UGCG Q16739 2/20 0.43
GBA2 Q9HCG7 2/20 0.43
SLC1A3 P43003 2/20 0.42
SLC1A2 P43004 2/20 0.42
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8073713 0.98 MMP3 (0.48) MMP3MMP8MMP9HTTSMN1; SMN2
SCHEMBL14739095 0.91 MMP3 (0.46) MMP3MMP8MMP9HTTSMN1; SMN2
Butane SCHEMBL11295410 0.89 TDP1 (0.47) MMP3MMP8MMP9HTTSMN1; SMN2
SCHEMBL2973368 0.87 TSHR (0.52) HTTSMN1; SMN2TSHRFOLH1L3MBTL1
SCHEMBL8609583 0.87 MMP3 (0.53) MMP3MMP8MMP9HTTSMN1; SMN2
SCHEMBL25120992 0.86 MMP3 (0.50) MMP3MMP8MMP9HTTSMN1; SMN2
SCHEMBL7573913 0.85 TDP1 (0.55) MMP3MMP8MMP9TSHRMMP1
SCHEMBL1768582 0.85 SLC1A1 (0.56) MMP3MMP8MMP9HTTSMN1; SMN2
SCHEMBL1768584 0.85 SLC1A1 (0.56) MMP3MMP8MMP9HTTSMN1; SMN2
SCHEMBL5857539 0.85 TDP1 (0.61) MMP3MMP8MMP9TSHRMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348362-A1 LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS Suzhou Abogen Biosciences Co., Ltd. (CN) 2023-11-02 US disclosed
US-5677432-A FORMING IMMUNOCONJUGATES FOR DETECTION OF ORGANOPHOSPHATE PESTICIDES THE HORTICULTURE AND FOOD RESEARCH INSTITUTE OF NEW ZEALAND LIMITED (NZ) 1997-10-14 US disclosed
EP-0629206-A1 IMMUNOLOGICAL DETECTION OF ORGANOPHOSPHATES THE HORTICULTURE AND FOOD RESEARCH INSTITUTE OF NEW ZEALAND LIMITED (NZ) 1994-12-21 EP disclosed
WO-1993017030-A1 IMMUNOLOGICAL DETECTION OF ORGANOPHOSPHATES THE HORTICULTURE AND FOOD RESEARCH INSTITUTE OF NEW ZEALAND LIMITED (NZ) 1993-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348362-A1 LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS CETP, NPC1, LCAT MMP3 3224/4885MMP8 3485/4885MMP9 2211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.